IP Library › Granted Patent US 11,484,610
Granted Patent B2
US 11,484,610 · App. 16/692,584 · Granted Nov 1, 2022

Method of treating melanoma

Inventors: Peter Novak (Sunny Isles Beach, FL); Maxim Temnikov (Miami, FL); Oleksandr Balakin (Dnepro petrovsk, UA)
Assignee: VECTOR VITALE IP LLC
A61K51/0476A61K31/164A61K33/30A61P35/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,484,610
App. No.
16/692,584
Granted
Nov 1, 2022
Kind
B2
Abstract

A method for treating melanoma or preventing the development of melanoma comprising administration of a composition comprising 64 Zn e (Asp) 2 in a therapeutically effective amount. Such administration may be via injection such as intratumoral and/or intravenous injection and may be once a day or more than once a day. A composition for the treatment of or prevention of melanoma comprising 64 Zn e (Asp) 2 in a therapeutically effective amount. The composition may be a liquid suitable for injection.

Claims (5)

1. A method of reducing melanoma tumor growth of a primary melanoma in a patient in need thereof, comprising suppressing tumor growth of the primary melanoma by administering by intratumorally and/or intravenously injecting a composition comprising a therapeutically effective amount of 64 Zn e (Asp) 2 in said patient; wherein from 0.1 mg/kg/day to 1 mg/kg/day of 64 Zn e (Asp) 2 is administered to the patient and wherein the 64 Zn e (Asp) 2 is at least 99% 64 Zn and the aspartate is at least 90% L-enantiomer.

2. The method of claim 1 , wherein the composition is an aqueous solution.

3. The method of claim 1 , wherein the composition is administered once a day.

4. The method of claim 1 , wherein the composition further comprises deuterium-depleted water as a solvent.

5. The method of claim 1 , wherein the composition is administered more than once a day.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2020
From: NOVAK, PETER Y.; TEMNIKOV, MAXIM V.
To: VECTOR VITALE IP LLC
Reel/Frame 052685/0221 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA PREVIOUSLY RECORDED AT REEL: 051949 FRAME: 0833. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 2, 2020
From: BALAKIN, OLEKSANDR
To: NOVAK, PETER Y.; TEMNIKOV, MAXIM V.
Reel/Frame 052064/0783 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2020
From: BALAKIN, OLEKSANDR
To: NOVAK, PETER; TEMNIKOV, MAXIM
Reel/Frame 051949/0833 →
Continuity (1)
Related Publication 20210154337A1 · May 27, 2021
Cited By (1)
US 12,734,240